Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer November 7, 2026 Genitourinary Cancer
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer November 7, 2026 Genitourinary Cancer
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) November 7, 2026 Genitourinary Cancer
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy November 7, 2026 Genitourinary Cancer
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy November 7, 2026 Genitourinary Cancer
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) November 7, 2026 Genitourinary Cancer
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors November 7, 2026 Genitourinary Cancer
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer November 7, 2026 Genitourinary Cancer
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial November 7, 2026 Genitourinary Cancer